4 May 2018 07:00
4 May 2018
AIM: AMYT
ESM: AYP
Amryt Pharma plc
("Amryt" or the "Company")
Posting of Annual Report 2017 and Notice of AGM
Amryt, the biopharmaceutical company focused on rare and orphan diseases, announces that copies of the Annual Report for the year ended 31 December 2017 have today been sent to shareholders along with the Notice of Annual General Meeting ("AGM"). Copies are also available from the Company's website, www.amrytpharma.com.
The AGM will be held at 10am on 5 June 2018 at Holiday Inn London Mayfair, 3 Berkeley Street, Mayfair, London W1J 8NE.
Enquiries:
Amryt Pharma plc | +353 (1) 518 0200 |
Joe Wiley, CEO Rory Nealon, CFO/COO
|
|
|
|
Shore Capital | +44 (0) 20 7408 4090 |
Nomad and Joint Broker |
|
Edward Mansfield, Mark Percy, Daniel Bush
|
|
|
|
Davy | +353 (1) 679 6363 |
ESM Adviser and Joint Broker |
|
John Frain, Anthony Farrell
|
|
Stifel | +44 (0) 20 7710 7600 |
Joint Broker |
|
Jonathan Senior, Ben Maddison
|
|
Consilium Strategic Communications | +44 (0) 20 3709 5700 |
Financial PR Adviser Amber Fennell Matthew Neal |
|
AMYT.L (AMYT)